This is a prospective cohort observational registry study that will include data on all patients who are treated at MHS facilities for COVID-19.
This is a prospective cohort observational registry study that will include data on all patients who are treated at MHS facilities for COVID-19. Data including, but not limited to demographics, comorbidities, medications, treatment, and clinical outcomes will be collected from February 2020 to December 2025. Subjects will undergo no additional tests or procedures as part of this registry study. All patient data will be obtained from the patient's electronic health records (EHR) of the hospital or clinic in a retrospective manner. The process for gathering the data will not influence treatment decisions. There will be no direct patient contact associated with inclusion in this registry study.
Study Type
OBSERVATIONAL
Enrollment
550
Patients treated for COVID-19
Clinical Research Institute Methodist Health System
Dallas, Texas, United States
Patient Characteristics
Patient characteristics
Time frame: June 2020 - Dec 2025
Treatment Measures and Intervention strategies
Treatment measures and intervention strategies
Time frame: June 2020 - Dec 2025
Clinical and survival outcomes
Clinical and survival outcomes
Time frame: June 2020 - Dec 2025
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.